United Kingdom

Takara Bio Inc (4974.T)

4974.T on Tokyo Stock Exchange

5:27am BST
Change (% chg)

¥-16 (-0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Wafergen Bio-Systems expects total revenue for Q4 2016 to be about $3.9 mln
Wednesday, 15 Feb 2017 

Wafergen Bio-systems Inc : Wafergen Bio-systems reports revenue growth in fourth quarter of 2016 . Sees FY 2016 revenue about $10.7 million . Wafergen Bio-Systems Inc - company expects total revenue for Q4 of 2016 to be approximately $3.9 million or a 62% increase .Wafergen Bio-Systems Inc - ended Q4 with cash of approximately $4.5 million, which includes initial $2.5 million advanced by Takara Bio USA Holdings, Inc.  Full Article

BRIEF-Takara Bio signs agreement for co-development and sales rights in Japan to NY-ESO-1 siTCRTM and CD19 CAR gene therapies

* Says it has entered into an agreement with Otsuka Pharmaceutical Co., Ltd for co-development and exclusive sales rights in Japan for Takara's NY-ESO-1 siTCRTM (TBI-1301, TBI-1301-A) and CD19 CAR (TBI-1501) gene therapies